Advertisement

Picture [iito] Männer Ballett 650x80px
Organisation › Details

Heptares Therapeutics Ltd. (Sosei Heptares)

We are an international biopharmaceutical group focused on the design and development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including CNS, immuno-oncology, gastroenterology, inflammation and other rare/specialty indications. Our leading clinical programs include partnered candidates aimed at the symptomatic treatment of Alzheimer’s disease (with Allergan) and next-generation immuno-oncology approaches to treat cancer (with AstraZeneca). Our additional partners and collaborators include Genentech, Novartis, Pfizer, Daiichi-Sankyo, PeptiDream, Kymab and MorphoSys. Sosei Heptares is headquartered in Tokyo, Japan with R&D facilities in Cambridge, UK. “Sosei Heptares” is the corporate brand of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565). *

 

Period Start 2007-01-01 splitoff
  Group Sosei (Group)
  Predecessor MRC (Medical Research Council, GB)
Products Industry drug discovery technology
  Industry 2 GPCR inhibitor
Persons Person Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983)
  Person 2 Kenny, Barry (Heptares 200910– CBO before Takeda Cambridge before Paradigm Therapeutics before Pfizer)
     
Region Region Welwyn Garden City, Hertfordshire
  Country United Kingdom (GB)
  Street Broadwater Road
BioPark Hertfordshire
  City AL7 3AX Welwyn Garden City, Hertfordshire
  Tel +44-1707-358-628
    Address record changed: 2019-08-07
     
Basic data Employees n. a.
     
    * Document for �About Section�: Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London.
     
   
Record changed: 2019-08-07

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Sosei (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81




» top